1,313
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Distribution characteristics and clinical phenotype analyses of hemoglobin variants in the Z region of Central Guangxi, Southern China

, , , , , & show all
Article: 2188651 | Received 06 Nov 2022, Accepted 01 Mar 2023, Published online: 30 Mar 2023

References

  • Hu TT, Guo H, Qin DQ, et al. Molecular diagnosis and hematological characteristics of abnormal hemoglobin J-Bangkok. Chin J Clin Lab Sci. 2020;38(03):171–174.
  • Xie JH, Wang GQ, Xiao QZ, et al. Screening and molecular diagnosis for abnormal hemoglobin. Lab Med. 2016;31(01):22–25.
  • Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155–167.
  • Ren TF. Screening analysis of abnormal hemoglobin disease in people of childbearing age in Xinyi district, guangdong province. Chin J Mod Drug Appl. 2021;15(06):240–242.
  • Pang YM, Wang XC, Pan HF, et al. A clinical study on genotype, hematological phenotype and iron overload of 1110 patients with hemoglobin H disease in Guangxi. Chin Youjiang Med J. 2019;47(05):336–342.
  • Keikhaei B, Rahim F, Zandian KH, et al. Comparison of different indices for better differential diagnosis of deficiency anemia from thalassemia trait. Blood. 2007;4(1):95.
  • He Y, Zhang YH, Wu RX, et al. Value of the combined tests of mean corpuscular volume, red cell osmotic fragility test and capillary hemoglobin electrophoresis in antenatal screening and diagnosis of thalassemia. Int J Lab Med. 2013;34(19):2521–2523 + 2525.
  • Deng YY, Li Y. Analysis the diagnostic value of Gap PCR and PCR-fluorescence probe in thalassemia. Gansu Med J. 2020;39(7):622–623.
  • Xiao QZ, Wang G, Li LX, et al. Verification application of PCR techniques with different principles in prenatal diagnosis of thalassemia. J Pract Med. 2017;33(6):994–996.
  • Jiao BQ, Li W, Liu F. Multiplex ligation-dependent probe amplification gene detection for diagnosis of 3 patients with Prader-Willi syndrome. Chin J Appl Clin Pediatrics. 2016;31(20):1580–1581.
  • Lv LN, Yang CH. Diagnosis and treatment status of thalassemia and molecular biology research. J Med Inf. 2022;35(11):33–36.
  • Tomonari M, Shun M, Masami Y. Mutation assay using single-molecule real-time (SMRT(TM)) sequencing technology. Genes Environ Official J Jpn Environ Mutagen Soc. 2015;37(1):15.
  • Xu XM. Guidelines of thalassenmia prevention and control programme. Beijing: People’s Military Medical Press; 2011.
  • Lin M, Wen YF, Wu JR, et al. Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern China. Plos One. 2013;8(2):e55024.
  • Yang H, Lin M, Lin F, et al. Molecular epidemiological investigation of abnormal hemoglobin in Shaokwan region, Southern China. Hematology. 2022-12-01;27(1):150–156.
  • Huang HL, Xu LP, Chen MH, et al. Molecular characterization of thalassemia and hemoglobinopathy in southeastern China. Sci Rep. 2019;9(1):3493.
  • de la Fuente-Gonzalo F, Nieto JM, Vinuesa L, et al. Hb cibeles [α2 CD25(B6) (Gly → Asp)]: a novel alpha chain variant causing alpha-thalassemia. Int J Hematol. 2014;100(6):599–601.
  • Durou MR, Ribault A, Dufour MJ, et al. Fortuitous diagnosis of the association of hemoglobin J-Broussais with beta + thalassemia. Ann Biol Clin. 1996;54(8-9):321–323.
  • Zhai YS, Tang HS, Li DZ. Hb J-Wenchang-Wuming [α11(A9)Lys→Gln (AAG > CAG) (α2 or α1)] compromises neonatal screening for α-thalassemia with the sebia Capillarys2 electrophoresis system. Hemoglobin. 2012;36(4):395–398.
  • Chen QQ, Xian JJ, Wang YC, et al. Molecular diagnosis and pedigree analysis of abnormal hemoglobin in hemoglobin UBE-2 combined with CD37 heterozygous. J Pract Med. 2022;38(4):5.
  • Panyasai S, Kongthai K, Phasit A. Association of Hb Shenyang [α26 (B7) Ala→Glu, GG > GG,: c.80C > A (or)] with several types of α-thalassemia in Thailand. Hemoglobin. 2020;44(5):354–360.
  • Recasens V, Montaés N, Rodríguez-Vigil C, et al. Why is the novel Hb miguel servet visualised by CE-HPLC newborn and not by the CE-HPLC β-thalassaemia programme?. J Clin Pathol. 2021;74(3):198–201.
  • Paleari R, Caruso D, Giavarini F, et al. The first case of Hb G-honolulu [α30(B11)Glu→Gln (GAG > CAG); HBA2:c.91G > A] observed in association with Hb S [β6(A3)Glu→Val, GAG > GTG] in a healthy Italian child. Hemoglobin. 2012;36(1):73–79.
  • Zeng YT, Huang SZ. Studies on Hb siriraj homozygote. J Genet Genomics. 1979;02:3-6 + 83–84.
  • Li YM, Jin X, Zhang YY, et al. Molecular characteristics and hematological phenotype of hemoglobin G in Shenzhen. Chin J Clin Lab Sci. 2020;38(03):180–183.
  • Wang YF, Wu BY, Xia WQ, et al. Hematologic phenotype and genotype analysis of patients with hemoglobin variants. J Exp Hematol. 2021;29(04):1280–1288.
  • Cheng ZR, Zhu XN, Zeng D, et al. Hb New York, preliminary results concerning the hematologic characteristics and the effects on thalassemia. Mol Biol Rep. 2022;49(7):6199–6205.
  • Elisabeth S, Kamran M, Fabrizio D, et al. Comparison of two known chromosomal rearrangements in the δβ-globin complex with identical DNA breakpoints but causing different Hb A(2) levels. Hemoglobin. 2012;36(2):177–182.
  • Efremov GD. Hemoglobins lepore and anti-Lepore. Hemoglobin. 2009;2(3):197–233.
  • Driscoll MC, Ohta Y, Nakamura F, et al. Hemoglobin miyada: DNA analysis of the anti-Lepore βδ fusion gene. Am J Hematol. 1984;17(4):355–362.
  • So CC, Chan A, Tsang S, et al. A novel beta-delta globin gene fusion leads to over-expression of delta globin chain and a mild thalassemia intermedia phenotype when Co-inherited with β0-thalassemia. Blood. 2006;108(11):1587–1587.